Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival

Author:

Kudryashova Tatiana V.123ORCID,Dabral Swati4,Nayakanti Sreenath4,Ray Arnab2ORCID,Goncharov Dmitry A.12,Avolio Theodore2,Shen Yuanjun12ORCID,Rode Analise2,Pena Andressa2,Jiang Lifeng1ORCID,Lin Derek1ORCID,Baust Jeffrey2,Bachman Timothy N.2,Graumann Johannes5ORCID,Ruppert Clemens6ORCID,Guenther Andreas6,Schmoranzer Mario4,Grobs Yann7,Eve Lemay Sarah7,Tremblay Eve7,Breuils-Bonnet Sandra7,Boucherat Olivier7ORCID,Mora Ana L.23,DeLisser Horace8,Zhao Jing9,Zhao Yutong9,Bonnet Sébastien7ORCID,Seeger Werner410ORCID,Pullamsetti Soni S.410,Goncharova Elena A.123ORCID

Affiliation:

1. Lung Center, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis School of Medicine (T.V.K., D.A.G., Y.S., L.J., D.L., E.A.G.).

2. Pittsburgh Heart, Lung and Blood Vascular Medicine Institute (T.V.K., A.R., D.A.G., T.A., Y.S., A.R., A.P., J.B., T.N.B., A.L.M., E.A.G.).

3. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh (T.V.K., A.L.M., E.A.G.).

4. Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (S.D., S.N., M.S., W.S., S.S.P.).

5. Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (J.G.).

6. Department of Internal Medicine, Justus Liebig University, Giessen, Germany (C.R., A.G.).

7. Department of Medicine, Faculty of Medicine, Université Laval, Quebec City, Canada (Y.G., S.E.L., E.T., S.B.-B., O.B., S.B.).

8. Department of Pathology and Laboratory Medicine, Pulmonary Vascular Disease Program, University of Pennsylvania Perelman School of Medicine, Philadelphia (H.D.).

9. The Ohio State University College of Medicine, Columbus (J.Z., Y.Z.).

10. Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Institute for Lung Health (ILH), Cardio-Pulmonary Institute (CPI), Justus Liebig University, Germany (W.S., S.S.P.).

Abstract

Rationale: The MSTs (mammalian Ste20-like kinases) 1/2 are members of the HIPPO pathway that act as growth suppressors in adult proliferative diseases. Pulmonary arterial hypertension (PAH) manifests by increased proliferation and survival of pulmonary vascular cells in small PAs, pulmonary vascular remodeling, and the rise of pulmonary arterial pressure. The role of MST1/2 in PAH is currently unknown. Objective: To investigate the roles and mechanisms of the action of MST1 and MST2 in PAH. Methods and Results: Using early-passage pulmonary vascular cells from PAH and nondiseased lungs and mice with smooth muscle-specific tamoxifen-inducible Mst1/2 knockdown, we found that, in contrast to canonical antiproliferative/proapoptotic roles, MST1/2 act as proproliferative/prosurvival molecules in human PAH pulmonary arterial vascular smooth muscle cells and pulmonary arterial adventitial fibroblasts and support established pulmonary vascular remodeling and pulmonary hypertension in mice with SU5416/hypoxia-induced pulmonary hypertension. By using unbiased proteomic analysis, gain- and loss-of function approaches, and pharmacological inhibition of MST1/2 kinase activity by XMU-MP-1, we next evaluated mechanisms of regulation and function of MST1/2 in PAH pulmonary vascular cells. We found that, in PAH pulmonary arterial adventitial fibroblasts, the proproliferative function of MST1/2 is caused by IL-6-dependent MST1/2 overexpression, which induces PSMC6-dependent downregulation of forkhead homeobox type O 3 and hyperproliferation. In PAH pulmonary arterial vascular smooth muscle cells, MST1/2 acted via forming a disease-specific interaction with BUB3 and supported ECM (extracellular matrix)- and USP10-dependent BUB3 accumulation, upregulation of Akt-mTORC1, cell proliferation, and survival. Supporting our in vitro observations, smooth muscle-specific Mst1/2 knockdown halted upregulation of Akt-mTORC1 in small muscular PAs of mice with SU5416/hypoxia-induced pulmonary hypertension. Conclusions: Together, this study describes a novel proproliferative/prosurvival role of MST1/2 in PAH pulmonary vasculature, provides a novel mechanistic link from MST1/2 via BUB3 and forkhead homeobox type O to the abnormal proliferation and survival of pulmonary arterial vascular smooth muscle cells and pulmonary arterial adventitial fibroblasts, remodeling and pulmonary hypertension, and suggests new target pathways for therapeutic intervention.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3